Literature DB >> 24783922

Effect of banxiaxiexin tang on treatment of functional dyspepsia: a meta-analysis of randomized controlled trials.

Yongkang Gan, Huayi Liu, Liu Yang, Kuo Yang.   

Abstract

OBJECTIVE: To evaluate the efficacy of Banxiaxiexin Tang compared with Western Medicine in the treatment of functional dyspepsia (FD) through Meta-analysis.
METHODS: Literature was searched in the following databases: MEDLINE, Excerpta Medica Database, Chinese Medical Current Contents, China Science and Technology Database, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. Randomized controlled trials evaluating the efficacy of Banxiaxiexin Tang for the treatment of FD were selected according to certain standards including clear general situation of patients, specific diagnostic criteria, definite clinical outcomes, etc. Articles were evaluated with quality assessment standards in the Cochrane Handbook for Systematic Reviews of Interventions. Meta-analysis was conducted with RevMan 5.0.23 software.
RESULTS: Ten articles with a total of 972 patients were included. The comparison of efficacy between Banxiaxiexin Tang and Western Medicine showed a combined effect size [OR = 2.75, 95% CI (1.86-4.07)] and combined effect of value of Z = 5.07 (P < 0.000 01), suggesting a significant difference between the groups.
CONCLUSION: Banxiaxiexin Tang was more effective than Western Medicine in treating FD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24783922     DOI: 10.1016/s0254-6272(14)60067-4

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  8 in total

1.  Banxia Xiexin tang for gastro-oesophageal reflux disease: A protocol for a systematic review of controlled trials.

Authors:  Bohyung Kang; Haesol Lee; Youkyung Choi; Chanyong Jeon; Ju Ah Lee
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

2.  1H NMR-Based Metabonomic Study of Functional Dyspepsia in Stressed Rats Treated with Chinese Medicine Weikangning.

Authors:  Yu Guo; Zhongfeng Li; Xinfeng Liu; Xiaolan Su; Yijie Li; Jiajie Zhu; Yilin Song; Ping Zhang; Jiande D Z Chen; Ruhan Wei; Jianqin Yang; Wei Wei
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-28       Impact factor: 2.629

3.  Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood.

Authors:  Shizhe Li; Tengfei Xu; Shu Liu; Zhiqiang Liu; Zifeng Pi; Fenrui Song; Yongri Jin
Journal:  R Soc Open Sci       Date:  2018-06-13       Impact factor: 2.963

4.  Herbal medicine Banha-sasim-tang for the treatment of functional dyspepsia protocol for a systematic review of randomized controlled trials.

Authors:  Seok-Jae Ko; Soo-Ho Cho; Keum-Ji Kim; Jin-Sung Kim; Na-Yeon Ha; Jae-Woo Park
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Complementary and alternative medicine for functional dyspepsia: An Asian perspective.

Authors:  Jin Young Yoon; Seok-Jae Ko; Jae-Woo Park; Jae Myung Cha
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

6.  Development of a patient-report pressure algometer for the quantification of abdominal examination.

Authors:  Seok-Jae Ko; Keun Ho Kim; Sang Hun Lee; Mi Hong Yim; Jae-Woo Park
Journal:  Integr Med Res       Date:  2021-05-24

Review 7.  Interstitial Cells of Cajal: Potential Targets for Functional Dyspepsia Treatment Using Medicinal Natural Products.

Authors:  Jin-Yong Joung; Seo-Hyung Choi; Chang-Gue Son
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

Review 8.  Chinese herbal medicine for functional dyspepsia: systematic review of systematic reviews.

Authors:  Michael H K Chu; Irene X Y Wu; Robin S T Ho; Charlene H L Wong; Anthony L Zhang; Yan Zhang; Justin C Y Wu; Vincent C H Chung
Journal:  Therap Adv Gastroenterol       Date:  2018-07-16       Impact factor: 4.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.